The goal of the Breast Cancer Program (BCP) is to facilitate the interactions of individuals concerned with studies on breast development and cancer. The goals of BCP members are to advance understanding of the mechanisms of breast cancer development and to translate information from the bench to the bedside. The BCP program has 24 members with their primary appointments in several departments at BCM, including the Breast Center, Medicine, Pathology, Molecular and Cellular Biology, Surgery, and Radiology. The BCP program has $5,757,823 in support from NCI and $9,143,556 in total peer reviewed support. Members of the program published 170 publications in 2006-2009, of which 24% represented intraprogrammatic collaborations and 30% interprogrammatic collaborations. Research in the basic sciences focuses on several themes, which include mechanisms of hormone and growth factor resistance, breast cancer stem cells, signaling networks in normal and breast cancer development, premalignant progression, and mechanisms of prevention of mammary carcinogenesis. The clinical/translational programs are multiple and supported in part by an NCI-funded Breast SPORE, which comprises five research projects. Other translational projects include the Stand Up 2 Cancer Program, a large multi-center study to molecularly subtype breast cancers with the goal to discover new therapeutic targets, a Komen Promise grant to discover new therapeutic targets involved in growth of ER-negative breast cancer and conduct clinical trials on the new targets, the Pan American Clinical Trials Network and several studies on gene signatures that predict prognosis. Clinical research is performed in the outpatient facilities of The Baylor Clinic and Ben Taub Hospital. Approximately 600 new breast cancer patients are seen yearly. Clinical members of the BCP are members and leaders in the NSABP and SWOG. There are 19 investigator-initiated clinical trials involve ER/growth factor crosstalk, targeting the HER/2 pathway, gene signatures predicting treatment response, and psychosocial/quality of life issues. Program interactions exist at multiple levels and include intra- and interprogrammatic research collaborations, research interactions with industry, educational activities and community outreach programs, patient advocate programs, and regularly scheduled research meetings and seminars. The program leaders are Daniel Medina, Ph.D., and Jenny C. N. Chang, M.D.

Public Health Relevance

The aims of the basic and translational experiments proposed are directly related to understanding the development, progression, and treatment of breast cancer, which is the second leading cause of cancer deaths in women in the USA. Basic research on the mechanisms of tumor resistance to hormonal or growth factor targeted therapy is translated into clinical trials. Similarly, the identification of cancer stem cells in preclinical models is translated into clinical studies evaluating the role of stem cells in therapeutic resistance.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA125123-07
Application #
8515951
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
7
Fiscal Year
2013
Total Cost
$57,331
Indirect Cost
$46,524
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Addison, Joseph B; Koontz, Colton; Fugett, James H et al. (2015) KAP1 promotes proliferation and metastatic progression of breast cancer cells. Cancer Res 75:344-55
Torbit, Lindsey A; Albiani, Jenna J; Crangle, Cassandra J et al. (2015) Fear of recurrence: the importance of self-efficacy and satisfaction with care in gay men with prostate cancer. Psychooncology 24:691-8
Thrift, Aaron P; Garcia, Jose M; El-Serag, Hashem B (2014) A multibiomarker risk score helps predict risk for Barrett's esophagus. Clin Gastroenterol Hepatol 12:1267-71
Bhattacharya, Abhisek; Parillon, Xyanthine; Zeng, Shenyan et al. (2014) Deficiency of autophagy in dendritic cells protects against experimental autoimmune encephalomyelitis. J Biol Chem 289:26525-32
Ramasamy, Ranjith; Ridgeway, Alex; Lipshultz, Larry I et al. (2014) Integrative DNA methylation and gene expression analysis identifies discoidin domain receptor 1 association with idiopathic nonobstructive azoospermia. Fertil Steril 102:968-973.e3
Kowalkowski, Marc A; Day, Rena S; Du, Xianglin L et al. (2014) Cumulative HIV viremia and non-AIDS-defining malignancies among a sample of HIV-infected male veterans. J Acquir Immune Defic Syndr 67:204-11
Geldres, Claudia; Savoldo, Barbara; Hoyos, Valentina et al. (2014) T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo. Clin Cancer Res 20:962-71
Young, Evelin; Zheng, Ze-Yi; Wilkins, Angela D et al. (2014) Regulation of Ras localization and cell transformation by evolutionarily conserved palmitoyltransferases. Mol Cell Biol 34:374-85
Anurathapan, Usanarat; Leen, Ann M; Brenner, Malcolm K et al. (2014) Engineered T cells for cancer treatment. Cytotherapy 16:713-33
Thrift, Aaron P; Kramer, Jennifer R; Alsarraj, Abeer et al. (2014) Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus. J Clin Gastroenterol 48:218-23

Showing the most recent 10 out of 272 publications